Roger Perlmutter
Patrimonio netto: 18 M $ in data 31/08/2026
Patrimonio netto: 18 M $ in data 31/08/2026
Dr. Roger M.
Perlmutter is an Independent Director at NGM Biopharmaceuticals, Inc., a Chairman & Chief Executive Officer at Eikon Therapeutics, Inc., an Independent Director at Insitro, Inc., a Chairman at The Reed Institute, a Member at American Academy of Arts & Sciences and a Science Partner at The Column Group LLC.
He is on the Board of Directors at NGM Biopharmaceuticals, Inc., Insitro, Inc., Exonics Therapeutics, Inc. and Institute for Systems Biology.
Dr. Perlmutter was previously employed as an Executive Vice President by Merck & Co., Inc., an Independent Director by Ablynx NV, a Non-Executive Director by Nxera Pharma UK Ltd., an Executive VP & Head-Research & Development by Amgen, Inc., an Independent Director by StemCells, Inc., a Non-Executive Director by Merck Research Laboratories Massachusetts LLC, an EVP-Worldwide Basic & Preclinical Research by Merck & Co., Inc., a Chairman-Immunology Department & Professor by University of Washington, a President & Director by Alantos Pharmaceuticals Holding, Inc., and a President by The American Association of Immunologists.
He also served on the board at Immune Design Corp.
and The Irvington Institute for Immunological Research.
He received his undergraduate degree from The Reed Institute and a doctorate degree from Washington University in St. Louis.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 02/03/2026 | 1.760.713 ( 3,25% ) | 18 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EIKON THERAPEUTICS, INC. | Amministratore Delegato | 01/05/2021 |
| NGM BIOPHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 08/06/2021 |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Direttore/Membro del Consiglio | 01/10/2020 |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Direttore/Membro del Consiglio | 30/01/2018 |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Corporate Officer/Principal | - |
The Reed Institute
The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Presidente | 21/06/2012 |
Institute for Systems Biology
Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Provides integration of technology, computation, biology and medicine | Direttore/Membro del Consiglio | 24/05/2013 |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Presidente | 01/01/2021 |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 20 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Reed Institute
The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Institute for Systems Biology
Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Provides integration of technology, computation, biology and medicine | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
The Irvington Institute for Immunological Research
The Irvington Institute for Immunological Research Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
The American Association of Immunologists
The American Association of Immunologists Miscellaneous Commercial ServicesCommercial Services The American Association of Immunologists is a professional organization dedicated to advancing immunology research, education, and public understanding of the immune system. The non-profit company is based in Bethesda, MD. It supports the immunology community through programs and resources, including annual meetings, summer courses, specialized programs, career development initiatives, fellowships, awards, travel grants, and mentoring resources. The association publishes two journals, The Journal of Immunology and ImmunoHorizons, and engages in advocacy and public policy related to vaccine policy, NIH funding, and research priorities. It also promotes diversity and inclusion through committees and initiatives for underrepresented minority scientists and provides educational content, public outreach, and advocacy resources. | Commercial Services |
Nxera Pharma UK Ltd.
Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Health Technology |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Health Technology |
Eikon Therapeutics, Inc.
Eikon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company that dedicated to inventing and developing of breakthrough therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale